According to Syndicate Market Research, the global Gene Synthesis Market hit about USD 0.95 billion in 2024. The Gene Synthesis Market industry is expected to reach around USD 1.1 billion in 2025 and a whopping USD 4.6 billion by 2034, growing at a steady compound annual growth rate (CAGR) of roughly 16.9% from 2026 to 2034. The report analyzes the Gene Synthesis Market's drivers, restraints, and the impact it has on demand during the forecast period. Furthermore, it will assist in navigating and exploring emerging market prospects.
The global Gene Synthesis Market involves the artificial creation of DNA sequences through chemical or enzymatic methods to produce custom genes for research, therapeutic, and industrial applications. This technology enables rapid and precise construction of genetic material that would otherwise require time-consuming natural extraction or cloning processes, serving as a foundational tool in synthetic biology, molecular biology, and biotechnology industries.
The market is propelled by surging demand for personalized medicine, gene therapies, and vaccine development alongside rapid technological advancements in DNA synthesis platforms that reduce costs and improve accuracy. However, restraints include high initial setup costs for advanced enzymatic methods and stringent regulatory oversight on gene-editing applications. Key trends encompass the integration of AI-driven design tools, expansion of cloud-based synthesis services, and growing adoption of long-sequence synthesis for complex therapeutic constructs.
Key Insights
Growth Drivers • Advancements in DNA synthesis technologies and synthetic biology applications
Continuous improvements in enzymatic synthesis methods and high-fidelity polymerases have drastically reduced turnaround times and error rates, enabling synthesis of longer and more complex genes that were previously challenging. This technological leap has accelerated research in CRISPR-based editing and metabolic engineering, creating sustained demand across academic and commercial laboratories.
Rising global funding for genomic research programs and strategic initiatives by governments to promote precision medicine further amplify market expansion, as both public and private sectors prioritize custom gene constructs for drug discovery and therapeutic development.
Restraints • High costs associated with long-sequence synthesis and regulatory complexities
Synthesizing genes longer than 5,000 base pairs remains expensive due to reagent costs and quality control requirements, limiting accessibility for smaller research entities and constraining overall market penetration in cost-sensitive regions. Stringent biosafety regulations and ethical concerns surrounding gene synthesis for potential dual-use applications add compliance burdens that slow commercialization timelines.
Additionally, intellectual property disputes over proprietary synthesis platforms occasionally hinder collaborative projects and technology transfer between academic institutions and industry players.
Opportunities • Emergence of AI-integrated design platforms and GMP-compliant manufacturing
AI-powered gene optimization software combined with automated synthesis facilities presents significant opportunities for rapid, error-free design-to-production workflows tailored for mRNA vaccines and cell therapies. Expansion of GMP-grade gene synthesis services opens new revenue streams in clinical-stage biopharmaceutical manufacturing.
Growing demand from agricultural biotechnology and industrial enzyme engineering in emerging economies creates untapped markets where customized genes can enhance crop resilience and sustainable biofuel production.
Challenges • Supply chain vulnerabilities and competition from next-generation sequencing alternatives
Dependence on specialized chemical reagents and enzymes exposes the market to global supply disruptions, while rapidly evolving next-generation sequencing technologies sometimes reduce the need for full gene synthesis in certain research workflows. Maintaining ultra-high accuracy for therapeutic-grade sequences while scaling production remains technically demanding.
Evolving international biosecurity policies require constant adaptation of screening protocols, increasing operational complexity for service providers serving global clients.
| Report Attributes | Report Details |
|---|---|
| Report Name | Gene Synthesis Market |
| Market Size in 2024 | USD 0.95 Billion |
| Market Size in 2025 | USD 1.1 Billion |
| Market Forecast in 2034 | USD 4.6 Billion |
| Growth Rate (2026-2034) | CAGR of 16.9% |
| Base Year | 2025 |
| Historical Year | 2020 - 2024 |
| Forecast Year | 2026 - 2034 |
| Number of Pages | 225 |
| Report Coverage | Revenue Forecast, Market Dynamics, Company Profile, Competitive Landscape, Recent Developments, Growth Factors, and Recent Trends |
| Key Companies Covered | GenScript Biotech Corporation, Twist Bioscience Corporation, Thermo Fisher Scientific Inc., Integrated DNA Technologies, and Others. |
| Segments Covered | By Method, By Application, By End-User, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, and The Middle East and Africa (MEA) |
| Customization Scope | Customization for Segments, Region, Country-level will be provided. Avail customized purchase options to meet your exact research needs. Request For Customization |
The Gene Synthesis Market is segmented by method, application, end-user, and region.
Based on Method Segment, The Gene Synthesis Market is divided into Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis, and others. Solid-phase Synthesis represents the most dominant segment with approximately 58% market share primarily because of its maturity, scalability, and proven reliability for producing standard-length genes at competitive prices, enabling it to drive market volume through widespread adoption in routine research and commercial projects. Chip-based Synthesis is the second most dominant segment as it offers massive parallelism and cost reductions for high-throughput applications, helping drive market growth by supporting large-scale library construction and synthetic biology initiatives.
Based on Application Segment, The Gene Synthesis Market is divided into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, Research & Development, and others. Gene & Cell Therapy Development dominates the application segment with around 52% share owing to the explosive growth in approved gene therapies and clinical pipelines that require precisely engineered DNA sequences for vector construction and editing tools; this segment drives the market by generating high-value, recurring orders from biopharma companies. Vaccine Development holds the second position as mRNA and viral vector platforms continue to expand globally, supporting market expansion through pandemic preparedness and emerging infectious disease programs.
Based on End-User Segment, The Gene Synthesis Market is divided into Biopharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations, and others. Biopharmaceutical Companies dominate with approximately 48% share due to their substantial R&D budgets and urgent need for custom genes in drug discovery and manufacturing scale-up, directly driving market revenue through large-volume contracts and long-term partnerships. Academic & Government Research Institutes represent the second most dominant segment as generous public funding and collaborative consortia fuel basic research and proof-of-concept studies, supporting overall market growth by creating steady demand for innovative synthesis services.
In 2025, Azenta Inc. (GENEWIZ) partnered with Form Bio to integrate next-generation sequencing with AI-powered analysis specifically for AAV gene therapy optimization, significantly enhancing vector design capabilities and accelerating clinical timelines for clients.
Twist Bioscience launched its Multiplexed Gene Fragments (MGFs) platform in late 2024, enabling high-throughput pools of double-stranded DNA up to 500 base pairs for rapid screening applications and capturing substantial share in synthetic biology research markets.
GenScript Biotech introduced the FLASH Gene service in 2024, offering ultra-fast sequence-to-plasmid delivery that reduces turnaround from weeks to days, addressing urgent needs in vaccine and therapeutic development pipelines worldwide.
In early 2025, Elegen Corporation commercialized its ENFINIA™ IVT Ready DNA product line designed for direct use in mRNA therapeutic manufacturing, eliminating weeks of additional processing and positioning the company as a leader in cell-free DNA production.
Ansa Biotechnologies expanded its early-access program for 50 kb DNA synthesis in 2025, delivering complex sequences in under four weeks and opening new possibilities for metabolic engineering and advanced cell therapy constructs.
North America to dominate the global market
North America leads the global Gene Synthesis Market with the highest share driven by its mature biotechnology infrastructure, massive venture capital inflows, and concentration of leading pharmaceutical and synthetic biology companies. The United States dominates the regional landscape through extensive NIH and NHGRI funding, FDA streamlined pathways for gene therapies, and presence of major players like Twist Bioscience and IDT that continuously invest in domestic manufacturing capacity.
Europe follows with steady growth supported by strong academic networks and EU Horizon programs focused on precision medicine. Germany and the United Kingdom dominate the European market through advanced research institutes and regulatory frameworks that encourage responsible gene synthesis innovation while maintaining strict biosafety standards.
Asia Pacific is emerging as the fastest-growing region fueled by government biotechnology initiatives and expanding biopharmaceutical manufacturing. China dominates the Asia Pacific landscape with aggressive investments in synthetic biology hubs and state-backed genomic research programs, while India and Japan contribute through cost-competitive service providers and growing clinical trial activity.
Latin America shows promising expansion supported by increasing healthcare investments and regional vaccine development programs. Brazil dominates the Latin American market through its strong agricultural biotechnology sector and rising adoption of gene synthesis for crop improvement alongside emerging therapeutic research.
The Middle East and Africa region is gradually gaining momentum driven by new research centers and international collaborations. South Africa and the United Arab Emirates dominate through strategic investments in genomics infrastructure and partnerships with global players to build local synthetic biology capabilities.
Some of the significant players in the global Gene Synthesis Market include;
By Method
By Application
By End-User
By Region
Frequently Asked Questions
What is Gene Synthesis Market? The Gene Synthesis Market refers to the global industry engaged in the artificial construction of DNA sequences using chemical and enzymatic methods to provide custom genes for research, therapeutic development, vaccine production, and industrial applications.
What are the principal factors expected to drive expansion in the Gene Synthesis Market between 2026 and 2034? Principal drivers include rapid advancements in enzymatic and chip-based synthesis technologies, surging demand for gene therapies and mRNA vaccines, increased government funding for synthetic biology, and growing adoption of AI-optimized gene design tools.
What is the projected market size of the Gene Synthesis Market from 2026 to 2034? (add both values) The market is projected to grow from approximately USD 1.3 billion in 2026 to USD 4.6 billion by 2034.
What overall growth rate (CAGR) is the Gene Synthesis Market predicted to achieve between 2026 and 2034? (full answers) The Gene Synthesis Market is predicted to achieve a compound annual growth rate (CAGR) of 16.9% between 2026 and 2034, supported by technological innovations and expanding therapeutic applications.
Which geographic region is forecasted to be a leading contributor to the overall Gene Synthesis Market valuation? North America is forecasted to be the leading contributor owing to its advanced biotechnology infrastructure, substantial R&D investments, and concentration of key industry players.
Who are the top companies dominating and driving the Gene Synthesis Market forward? (mention all companies in this table which you providing in Competitive Players) The top companies include GenScript Biotech Corporation, Twist Bioscience Corporation, Thermo Fisher Scientific Inc. (GeneArt), Integrated DNA Technologies (IDT), Eurofins Genomics, Azenta Inc. (GENEWIZ), Bioneer Corporation, Merck KGaA, DNA 2.0 (ATUM), and Bio Basic Inc.
What key information or findings can typically be expected from the global Gene Synthesis Market report? The report delivers detailed market sizing, growth forecasts, segmentation breakdowns, regional analysis, competitive landscape, recent strategic developments, drivers, restraints, and emerging technology trends.
What are the various stages in the value chain of the global Gene Synthesis Market industry? The value chain encompasses oligonucleotide design and sequence optimization, raw material procurement and synthesis, post-synthesis purification and quality validation, cloning into vectors when required, final product packaging, distribution, and end-user application in research or manufacturing.
How are current market trends and evolving consumer preferences influencing the Gene Synthesis Market? Trends toward longer-sequence synthesis, AI-assisted design, and demand for GMP-compliant materials are shifting preferences toward faster, more accurate, and regulatory-ready services while researchers increasingly seek cloud-based ordering platforms for convenience.
What regulatory changes or environmental factors are impacting the growth of the Gene Synthesis Market? Biosecurity screening mandates, evolving guidelines on dual-use research of concern, and international harmonization of synthetic DNA oversight are shaping growth, alongside environmental considerations around reagent sustainability and waste reduction in high-throughput facilities.
These players adopted different strategies so as to hold major market share in this market. Some of the major players in [keyword] industry includes. [players list]
Based on the [keyword] market analysis, North America is predicted to held the highest share in the [keyword] market during the forecast period.
The statistical data of the top market players of [keyword] industry can be obtained from the company profile section specified in the report. This section incorporates analysis of top player’s operating in the [keyword] industry as well as their last five-year revenue, segmental revenue, product offerings, key strategies adopted, and geographical revenue produced.
The study offers a decisive view on the [keyword] by segmenting the market based on [segment1], [segment2], and region.
The report gives a nitty-gritty assessment of the market by featuring data on various viewpoints that incorporate drivers, restraints, opportunities, and threats. This data can assist stakeholders in making suitable decisions before investing.
The sample for [keyword] market report can be received on-demand from the website as and when required.Direct call services or 24*7 chat support are provided to procure the sample report.
1.1 Research Methodology
The process of market research at Syndicate Market Research is an iterative in nature and usually follows following path. Information from secondary is used to build data models, further the results obtained from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new information is again incorporated into data model. The process continues till desired level of information is not generated.
To calculate the market size, the report considers the revenue generated from the sales of the market providers. The revenue generated from the sales of market is calculated through primary and secondary research. The key players operating in the market across the globe are identified through secondary research and a corresponding detailed analysis of the top vendors in the market is done. The market size calculation also includes clinical trial phase segmentation determined using secondary sources and verified through primary sources.
1.2 Secondary Research
The secondary research sources that are typically referred to include, but are not limited to:
The sources for secondary research includes but is not limited to: Factiva, Hoovers and Statista
1.3 Primary Research
We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
The participants who typically take part in such a process include, but are not limited to:
1.4 Models
Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data types to produce estimates:
Data is then cross checked by the expert panel.
1.4.1 Company Share Analysis Model
Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps:
1.4.2 Revenue Based Modeling
Revenue based models can be built in two ways - Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
1.5 Research Limitations
Inflation is not a part of pricing in this report. Prices of the products and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each type has been taken into account while estimating and forecasting market revenue on a global basis. Regional average price has been considered while breaking down this market by end user in each region.
We focus on the quality and accuracy of the report
Our expert team will assist with all your research needs and customize the report
Get you queries resolved from our expert analysts before and after purchasing the report
Instant delivery in the form of a PDF/PPT/Word Doc to your email address, within 12 hours after receiving the full payment.
Analysts will provide deep insights about the reports
* We value your privacy and will never rent or sell your email address.
Comprehensive & Focused Market Reports Large Archive of Excellent Market and Industry Analysis Reports that Deliver Business Intelligence.
Safe & Secure Payment Solutions
Enabled by SSL, we provide you numerous safe payment options for
risk-free transactions.
Superior Customer Experience We serve our
customers through calls, emails and live chats for 365 days, 24x7.
Syndicate Market Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. Read More
We accept the following payment methods
